Corpay Cross-Border Named the Official Commercial FX Partner of Prima Pramac Racing February 17, 2026 Providing access to currency risk management and cross-border payments solutions
Allegion (NYSE: ALLE) Reports Q4, Full-Year 2025 Financial Results, Introduces 2026 Outlook February 17, 2026 High-Single Digit Revenue Growth for the Enterprise and Continued Strength in Americas Non-Residential Quarterly Financial Highlights (All comparisons are year-over-year, unless otherwise noted) Net earnings per share (EPS) of $1.70, up 3.0% compared with $1.65; Adjusted EPS of $1.94, up 4.3% compared with $1.86 Revenues of $1,033.2 million, up 9.3% on a reported basis and up 3.3% on an organic basis Operating margin of 20.3%, compared with 19.5%; Adjusted operating margin of 22.4%, compared with 22.1% Full-Year Financial Highlights (All comparisons are year-over-year, unless otherwise noted) EPS of $7.44, up 9.1% compared with $6.82; Adjusted EPS of $8.14, up 8.1% compared with $7.53 Revenues of $4,067.3 million, up 7.8% on a reported basis and up 4.1% on an organic basis Operating margin of 21.1%, compared with 20.7%; Adjusted operating margin of 23.2%, up 40 basis points compared with 22.8% Available cash flow, which is defined as net cash from operating activities minus capital expenditures, was $685.7 million for 2025, an increase of 17.6% 2026 Full-Year Outlook Highlights Full-year reported revenue growth is estimated to be 5% to 7%, with organic revenue growth estimated to be 2% to 4% Full-year adjusted EPS is estimated to be $8.70 to $8.90 Available cash flow is estimated to be 85% to 95% of adjusted net income
Endava Partners with Miro to Drive Innovative New Model for AI Transformation February 17, 2026 Strategic partnership embeds Miro AI platform across Endava's global offering to strengthen its AI-native delivery model
Winter Olympics 2026: How insurance keeps Milano Cortina on track February 17, 2026 Every four years, the world’s greatest athletes fight to take gold, but it’s the unseen safety nets, drafted by insurers, that keep the Winter Olympics running smoothly. German-based Allianz became the exclusive insurance partner of the International Olympic Committee (IOC) in 2021, with coverage until the 2032 summer games in Brisbane, under the oversight of [...]
Why the UK is losing the AI skills race February 16, 2026 What's the use in being the third largest AI market in the world if our workforce doesn't know how to use it, asks IBM's Leon Butler.
Youri Djorkaeff on investing, SailGP and buying an English football club February 16, 2026 French football legend Youri Djorkaeff and his son Sacha on their investment vehicle Playmaker, backing SailGP and buying an English club. Two years after helping his country to win a home World Cup in 1998, Youri Djorkaeff was ticking off another life goal in France colours. Only this time it was on the waters around [...]
Nigel Farage’s war on working from home is vibes-based politics February 16, 2026 Nigel Farage's attack on working from home is designed to increase headlines, not productivity, writes Eliot Wilson.
Non-cash ISA understanding low despite government push February 16, 2026 UK savers understanding of non-cash ISA products, is lower than its cash counterpart, reflecting the lack of knowledge surrounding options despite the government push to move Brits away from cash. According to the latest analysis from investment platform Robinhood, just under half of investors confirmed having minimal knowledge of how stocks and shares ISAs work, [...]
New ECCO data show subcutaneous (SC) infliximab (Remsima™ SC) effectively recaptures and maintains disease control after drug holiday February 16, 2026 A new post-hoc analysis from the LIBERTY studies, presented at ECCO 2026, demonstrated that initiating subcutaneous (SC) infliximab (Remsima™ SC) after a treatment interruption following intravenous (IV) infliximab induction helps patients with Crohn’s disease (CD) and ulcerative colitis (UC) recapture and maintain disease control1 The results demonstrated that SC infliximab provides an effective and safe option to regain clinical control after a planned or unplanned treatment interruption More than a total of 30 accepted abstracts including one oral and one digital oral presentation and eight posters, reinforce Celltrion’s commitment to inflammatory bowel disease (IBD) research aimed at enhancing patient outcomes
Sultan bin Ahmed Visits Shanghai Film Studios, Film Park and Stadium February 15, 2026 His Highness Sheikh Sultan bin Ahmed bin Sultan Al Qasimi, Deputy Ruler of Sharjah and Chairman of the Sharjah Media Council, visited the 800,000-square-metre Shanghai Film Studios and Film Park in the town of Shidon in the Chinese city of Shanghai on Saturday. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260215440594/en/ His [...]